Intra-abdominal infections (IAIs) are common surgical emergencies and have been reported as major contributors to non-trauma deaths in the emergency departments worldwide.The cornerstones of effective treatment of IAIs are early recognition, adequate source control, and appropriate antimicrobial therapy. Prompt resuscitation of patients with ongoing sepsis is of utmost important.In hospitals worldwide, non-acceptance of, or lack of access to, accessible evidence-based practices and guidelines result in overall poorer outcome of patients suffering IAIs.The aim of this paper is to promote global standards of care in IAIs and update the 2013 WSES guidelines for management of intra-abdominal infections.
A 26-year-old white woman in the 35th week of pregnancy presented with severe dyspnea due to massive bilateral chylothorax, necessitating a low transverse cesarean section for delivery of a healthy baby.Conservative treatment consisting of bilateral closed tube thoracostomy and total parenteral nutrition was instituted but proved ineffective. A left thoracotomy was performed and multiple small lymphatic channels were ligated at the esophageal hiatus on both sides along with all tissue between the aorta and the azygos vein. After surgery the chyle effusion ceased and the patient was discharged on postoperative day 14. Although a chest CT scan 1 year after surgery did not show any abnormality in the lungs, pleurae or mediastinum, the patient (who was HIV negative) still presented with a severe combined immunodeficiency. Although an abdominal CT scan revealed numerous rounded, non-enhancing splenic lesions up to 1 cm l Corresponding author,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.